What's New

Last Posted: Sep 29, 2020

• Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis.
  Shamanna Paramesh et al. Diabetes therapy : research, treatment and education of diabetes and related disorders 2020 Sep
• IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
  Chou Chia-Hsuan et al. International journal of molecular sciences 2020 Aug 21(16)
• Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone.
  Diamond David M et al. BMJ evidence-based medicine 2020 Jul
• Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients.
  Xhakaza Lettilia et al. Drug metabolism and personalized therapy 2020 Jun
• Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
  Engwa Godwill Azeh et al. Endocrine, metabolic & immune disorders drug targets 2020 Apr
• New clinical screening strategy to distinguish HNF1A variant-induced diabetes from young early-onset type 2 diabetes in a Chinese population.
  Ma Yumin et al. BMJ open diabetes research & care 2020 Mar 8(1)
• Lifestyle intervention modifies the effect of the MC4R genotype on changes in insulin resistance among women with prior gestational diabetes: Tianjin Gestational Diabetes Mellitus Prevention Program.
  Chen Yuhang et al. The American journal of clinical nutrition 2019 110(3) 750-758
• An unsupervised learning approach to identify novel signatures of health and disease from multimodal data.
  Shomorony Ilan et al. Genome medicine 2020 Jan 12(1) 7
• Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach.
  Franck Maximilien et al. Lifestyle genomics 2019 Nov 1-11
• Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.
  Caffarelli Carlo et al. Italian journal of pediatrics 2016 Aug 42(1) 75
• High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women.
  Kim Sung-Hoon et al. Gynecologic and obstetric investigation 2019 84(3) 225-236
• Genomics and PCOS
  Genomics Education UK, August 5, 2019
• TyG-er: An ensemble Regression Forest approach for identification of clinical factors related to insulin resistance condition using Electronic Health Records.
  Bernardini Michele et al. Computers in biology and medicine 2019 Jul 112103358
• Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
  Shabani Azade et al. Journal of affective disorders 2019 25051-56
• Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.
  Depommier Clara, et al. Nature medicine 2019 7 0. (7) 1096-1103